Review
Sep 2026
NLRP3 Inflammasome Inhibitors as Precision Anti-inflammatory Pharmacotherapy: Translational Advances, Clinical Evidence, and Disease-specific Challenges.
Mohib Raza, Alok Kumar, Hibah et al.
· InflammoPharmacology · 0 citations